Advanced Bladder Cancer COE

Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials -Pedro Barata Details (Length of Discussion: 21 min) Petros Grivas and Pedro Barata discuss how a recent study they performed applies to the field of metastatic urothelial cancer regarding the use of checkpoint inhibitors in a patient population outside the context of the clinical trial and the main objectives, results, and conclusion of that study as well as implications for the field. Biographies: Pedro Barata, MD, M...
The State of Advanced Bladder Cancer - New Data from AACR 2018 - Interview with Arjun Balar Details (Length of Discussion: 30 min) Arjun Balar, MD overviews his presentation from the American Association for Cancer Research Annual Meeting (AACR 2018) meeting on durvalumab plus tremelimumab, combination data in patients with metastatic urothelial cancer. A phase I, Study 10, of data which shows clinical activity with combination treatment in 2nd-line metastatic urothelial carcinoma. A study desig...

Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials -Pedro Barata